Objective: To assess characteristics of MS lesions and normal appearing white matter (NAWM) with various imaging modalities. Glucose metabolism was investigated with FDG - PET, metabolite concentration with proton NMR spectroscopy, and lesion detection with routine brain MRI. Methods: Thirteen patients were studied in a stable phase of their disease, and two during an acute episode. Nine healthy volunteers served as controls. Results: Three patients had a normal brain MRI, 12 had typical lesions. MR images were registered to the PET planes. Lesions and contra-lateral control areas were analyzed, 10/15 lesions showed relative hyper-metabolism and 2 hypo-metabolism. NAA concentration was significantly decreased in both lesions and NAWM. Conclusion: In stable MS, most large lesions have a relatively increased glucose utilization and decreased NAA concentration. NAWM showed a significantly decreased NAA concentration compared to healthy subjects, but no difference in glucose metabolism. Active lesions in acute MS are also hyper-metabolic. This finding opens a new window on the classification of white matter lesions based on glucose utilization.
Allen I. (1991) Pathology of multiple sclerosis, In: Matthews, ed. McAlpine's Multiple Sclerosis , Edinburgh, pp 341-378.
2.
Paty DW, Li Dkb, Koopmans R. (1992) MRI in monitoring the treatment of multiple sclerosis: concerted action guidelines. J Neurol NeuroSurg Psy55: 978.
3.
Miller DH, McDonald WI (1994) Neuroimaging in multiple sclerosis. Clinical Neuroscience2: 215 - 224.
4.
Barkhof F. et al. (1992) Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activityAmer J Radiol159: 1041-1047.
5.
Van Hecke P. et al. (1991) Human brain proton localized NMR spectroscopy in multiple sclerosis. Magn Reson Med18: 199 - 206.
6.
Filippi M. et al. (1995) A brain MRI study of different types of chronic-progressive multiple sclerosis. Acta Neurol Scand91: 231 - 233.
7.
Ernst T., Kreis R., Ross B. ( 1992) Absolute quantification of water and metabolites in the human brain. I. Compartments and water. J Magn ResonB102: 1 - 8.
8.
Michaelis T. et al. (1993) Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton NMR spectra. Radiology187: 219 - 227.
9.
Woods RP, Mazziotta JC, Cherry SR (1993) MRI-PET registration with automated algorithm. J Comput Assist Tomogr17: 536 - 546.
10.
Phelps ME et al. (1979) Tomographic measurements of local cerebral glucose metabolic rate in humans with (F-18)-fluoro-2-deoxy-glucose: validation of the method. Ann Neurol6: 371 - 388.
11.
Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol13: 227 - 231.
12.
Mazziotta JC, Phelps ME (1986) Positron emission tomography studies of the brain . In: Phelps ME, Mazziotta JC, Schelbert HR , (eds) Positron emission tomography and autoradiography: principal applications for the brain and the heart. Raven Press: New York, pp 493 - 580.
13.
Heiss WD et al. (1982) Atlas of positron emission tomography of the brain. Heidelberg, Germany, Springer Verlag, pp 47 - 91.
14.
Wang GJ et al. (1994) Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med35: 1457 - 1466.
15.
Loessner A. et al. (1995) Regional cerebral function determined by FDG PET in healthy volunteers: normal patterns and changes with age. J Nucl Med36: 1141-1149.
16.
Martinelli V. et al. (1990) Cognitive impairment in multiple sclerosis: correlations between neuropsychological tests, brain MRI, long latency SEP's and PET. Riv Neurobiol36: 551 - 557.
17.
Pozzilli C. et al. (1991) SPECT, MRI and cognitive functions in multiple sclerosis. J Neurol Neurosurg and Psychiat54: 110 - 115.
18.
Lycke J. et al. (1993) Regional cerebral blood flow in multiple sclerosis measured by single photon emission tomography with Tc-99m HMPAO . Eur Neurol33: 163-167
19.
Larson SM (1994) Cancer or inflammation? A holy Grail for nuclear medicine. J Nucl Med35: 1653 - 1655 (Editorial).
20.
Kubota R. et al. (1992) Intra-tumoral distribution of F-18-Fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by micro-autoradiography. J Nucl Med33: 1972 - 1980.
21.
Kolmel HW, Von Maravic M. (1988) Correlation of lactic acid level, cell count and cytology in cerebrospinal fluid of patients with bacterial and non-bacterial meningitis. Acta Neurol Scand78: 6 - 9.
22.
Miller DH, Barkhof F., Nauta Jjp. (1993) Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain116: 1077-1094.
23.
Minderhoud JM et al (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol49: 161 - 165.
24.
Husted CA et al. (1994) Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in-vivo 31p and 1H spectroscopic imaging. Ann Neurol36: 157-165.
25.
Christiansen P. et al. (1993) In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging11: 107 - 118.
26.
Larsson Hbw , Frederiksen LK, Henriksen O., Olesen J. (1988) In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis . Magn Reson Med25: 743 - 755.
27.
Tourtellotte WW, Parker JA (1968) Some spaces and barriers in postmortem multiple sclerosis. In: Progress in Brain Research, vol 29, Lajtha A, Ford DH, (eds) Elsevier: Amsterdam , pp 493 - 525.
28.
MacKay A. et al. (1994) In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med31: 673 - 677.
29.
Arnold DL et al. (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol36: 76 - 82.
30.
Hiehle JF et al. (1994) Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med32: 32: 285 - 293.
31.
Bruhn H. et al. (1992) Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol32: 140 - 150.
32.
Grossman RI et al. (1992) MR proton spectroscopy in multiple sclerosis. AJNR13: 1535 - 1543.
33.
Matthews PM , Francis G., Antel J., Arnold DL (1991) Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis . Neurology41: 1251-1256.
34.
Davie CA, Hawkins CP, Barker GJ (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain117: 49 - 58.
35.
Koopmans RA et al. (1993) Magnetic resonance spectroscopy of multiple sclerosis: In vivo detection of myelin breakdown product. Lancet341: 631-632.
36.
Van Hecke P. et al. (1991) Localized brain proton MS spectroscopy of chronic MS patients. European Congress oif RadiologyS1226.
